In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Protagonist Therapeutics Inc (NASDAQ: PTGX) closed the day trading at $37.44 down -0.56% from the previous closing price of $37.65. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 0.63 million shares were traded. PTGX stock price reached its highest trading level at $38.62 during the session, while it also had its lowest trading level at $36.92.
Ratios:
For a better understanding of PTGX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.72 and its Current Ratio is at 15.72. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, CapitalOne on October 30, 2023, initiated with a Overweight rating and assigned the stock a target price of $32.
On August 25, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $21.JMP Securities initiated its Mkt Outperform rating on August 25, 2022, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 24 ’24 when Waddill William D. sold 8,000 shares for $40.00 per share. The transaction valued at 320,000 led to the insider holds 12,000 shares of the business.
PATEL DINESH V PH D sold 35,000 shares of PTGX for $1,231,650 on Jun 07 ’24. The President and CEO now owns 515,415 shares after completing the transaction at $35.19 per share. On Jun 07 ’24, another insider, Waddill William D., who serves as the Director of the company, sold 8,000 shares for $35.00 each. As a result, the insider received 280,000 and left with 12,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTGX now has a Market Capitalization of 2262993408 and an Enterprise Value of 1886079744. As of this moment, Protagonist’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.97 while its Price-to-Book (P/B) ratio in mrq is 3.91. Its current Enterprise Value per Revenue stands at 5.988 whereas that against EBITDA is 12.604.
Stock Price History:
Over the past 52 weeks, PTGX has reached a high of $42.67, while it has fallen to a 52-week low of $13.72. The 50-Day Moving Average of the stock is 10.65%, while the 200-Day Moving Average is calculated to be 42.69%.
Shares Statistics:
Over the past 3-months, PTGX traded about 935.86K shares per day on average, while over the past 10 days, PTGX traded about 708320 shares per day. A total of 57.71M shares are outstanding, with a floating share count of 55.40M. Insiders hold about 5.55% of the company’s shares, while institutions hold 99.19% stake in the company. Shares short for PTGX as of 1721001600 were 3262628 with a Short Ratio of 3.49, compared to 1718323200 on 3117841. Therefore, it implies a Short% of Shares Outstanding of 3262628 and a Short% of Float of 5.6399997.
